• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大肠杆菌奈瑟 1917 菌影的体外与体内摄取研究:用于眼部表面疾病靶向治疗的基于细胞的递药系统。

In vitro and in vivo uptake study of Escherichia coli Nissle 1917 bacterial ghosts: cell-based delivery system to target ocular surface diseases.

机构信息

Medical University Vienna, OCUVAC-Laura Bassi Centres of Expertise, Institute of Specific Prophylaxis and Tropical Medicine, Centre of Pathophysiology, Infectiology and Immunology, Vienna, Austria.

出版信息

Invest Ophthalmol Vis Sci. 2013 Sep 24;54(9):6326-33. doi: 10.1167/iovs.13-12044.

DOI:10.1167/iovs.13-12044
PMID:23920373
Abstract

PURPOSE

For the successful topical administration of drugs or vaccines to treat ocular surface diseases, efficient and well-tolerated delivery systems/carriers for conjunctival delivery are crucial in the development of new treatment strategies. The present study investigated the efficiency of internalization of bacterial ghosts (BGs) produced from probiotic Escherichia coli Nissle 1917 (EcN) by human conjunctival epithelial (HCjE) cell line, the EcN BGs cytotoxicity for HCjE cells, and in vivo uptake of EcN BGs by conjunctival guinea pig epithelial cells.

METHODS

The uptake of EcN BGs by HCjE cells was analyzed by laser scanning microscopy and flow cytometry. Immunohistochemistry was used to localize the EcN BGs in the guinea pig conjunctival tissue. Cytotoxicity of EcN BGs on HCjE cells was evaluated by measurement of LDH.

RESULTS

Laser scanning microscopy and flow cytometry revealed that EcN BGs internalization by HCjE cells was time- and dose dependent. No cytotoxic effect on HCjE cells was observed after EcN BGs inoculation for 30 and 120 minutes, as well as 24 hours. In addition, the uptake of EcN BGs was detected in the conjunctival cells after in vivo administration of EcN BGs into the eye of the guinea pig.

CONCLUSIONS

The findings that EcN BGs are nontoxic and effectively internalized in vitro by human and in vivo by guinea pig conjunctival cells comprise an important contribution to the future use of BGs as a system for conjunctival delivery of drugs and vaccines, either to treat or prevent ocular surface diseases.

摘要

目的

为了成功地将药物或疫苗局部应用于治疗眼表疾病,开发新的治疗策略时,对于结膜给药而言,高效且耐受良好的传递系统/载体对于益生菌大肠杆菌 Nissle 1917(EcN)生产的细菌体(BGs)至关重要。本研究调查了人结膜上皮(HCjE)细胞系内化由益生菌大肠杆菌 Nissle 1917(EcN)产生的细菌体(BGs)的效率、EcN BGs 对 HCjE 细胞的细胞毒性以及结膜豚鼠上皮细胞对 EcN BGs 的体内摄取。

方法

通过激光扫描显微镜和流式细胞术分析 EcN BGs 被 HCjE 细胞摄取的情况。免疫组织化学用于定位豚鼠结膜组织中的 EcN BGs。通过测量 LDH 评估 EcN BGs 对 HCjE 细胞的细胞毒性。

结果

激光扫描显微镜和流式细胞术显示 EcN BGs 被 HCjE 细胞内化呈时间和剂量依赖性。EcN BGs 接种 30 分钟和 120 分钟以及 24 小时后,对 HCjE 细胞没有观察到细胞毒性作用。此外,在将 EcN BGs 体内给药到豚鼠眼睛后,在结膜细胞中检测到 EcN BGs 的摄取。

结论

EcN BGs 在体外对人、体内对豚鼠结膜细胞无毒且有效内化的发现,为将来将 BGs 用作药物和疫苗的结膜传递系统,以治疗或预防眼表疾病,做出了重要贡献。

相似文献

1
In vitro and in vivo uptake study of Escherichia coli Nissle 1917 bacterial ghosts: cell-based delivery system to target ocular surface diseases.大肠杆菌奈瑟 1917 菌影的体外与体内摄取研究:用于眼部表面疾病靶向治疗的基于细胞的递药系统。
Invest Ophthalmol Vis Sci. 2013 Sep 24;54(9):6326-33. doi: 10.1167/iovs.13-12044.
2
Bacterial Ghosts as antigen and drug delivery system for ocular surface diseases: Effective internalization of Bacterial Ghosts by human conjunctival epithelial cells.细菌幽灵作为眼部疾病的抗原和药物传递系统:人结膜上皮细胞对细菌幽灵的有效内化。
J Biotechnol. 2011 May 20;153(3-4):167-75. doi: 10.1016/j.jbiotec.2011.03.022. Epub 2011 Apr 8.
3
Escherichia coli Nissle 1917 bacterial ghosts retain crucial surface properties and express chlamydial antigen: an imaging study of a delivery system for the ocular surface.大肠杆菌Nissle 1917细菌幽灵保留关键表面特性并表达衣原体抗原:眼表递送系统的成像研究
Drug Des Devel Ther. 2015 Jul 21;9:3741-54. doi: 10.2147/DDDT.S84370. eCollection 2015.
4
Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers.使用颗粒载体将衣原体粘附素N-PmpC亚单位疫苗递送至眼黏膜
PLoS One. 2015 Dec 11;10(12):e0144380. doi: 10.1371/journal.pone.0144380. eCollection 2015.
5
Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance.壳聚糖纳米颗粒作为一种潜在的眼表药物递送系统:毒性、摄取机制及体内耐受性
Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1416-25. doi: 10.1167/iovs.05-0495.
6
Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.用于在体内检测益生菌微生物大肠杆菌Nissle 1917菌株(EcN)的绿色荧光蛋白。
J Microbiol Methods. 2005 Jun;61(3):389-98. doi: 10.1016/j.mimet.2005.01.007.
7
Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.益生菌大肠杆菌 Nissle 1917 对 O104:H4 和 O157:H7 血清型肠出血性大肠杆菌菌株的拮抗作用。
Int J Med Microbiol. 2013 Jan;303(1):1-8. doi: 10.1016/j.ijmm.2012.11.006. Epub 2013 Jan 10.
8
Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair.大肠杆菌Nissle 1917益生菌作用的分子机制涉及ZO-2和PKCζ的重新分布,从而导致紧密连接和上皮屏障修复。
Cell Microbiol. 2007 Mar;9(3):804-16. doi: 10.1111/j.1462-5822.2006.00836.x. Epub 2006 Nov 3.
9
Construction and In Vitro Evaluation of a Tumor Acidic pH-Targeting Drug Delivery System Based on Nissle 1917 Bacterial Ghosts.基于1917株Nissle菌的肿瘤酸性pH靶向药物递送系统的构建及体外评价
Bioengineering (Basel). 2022 Sep 2;9(9):433. doi: 10.3390/bioengineering9090433.
10
Escherichia coli Nissle 1917 ghosts alleviate inflammatory bowel disease in zebrafish.大肠杆菌 Nissle 1917 无细胞菌体能缓解斑马鱼的炎症性肠病。
Life Sci. 2023 Sep 15;329:121956. doi: 10.1016/j.lfs.2023.121956. Epub 2023 Jul 19.

引用本文的文献

1
Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy.细菌衍生物介导的药物传递在癌症治疗中的应用:新一代策略。
J Nanobiotechnology. 2024 Aug 24;22(1):510. doi: 10.1186/s12951-024-02786-w.
2
Deciphering the Potential of Probiotics in Vaccines.解读益生菌在疫苗中的潜力。
Vaccines (Basel). 2024 Jun 26;12(7):711. doi: 10.3390/vaccines12070711.
3
Advances in bacteria-based drug delivery systems for anti-tumor therapy.基于细菌的抗肿瘤治疗药物递送系统的研究进展。
Clin Transl Immunology. 2024 Jun 26;13(7):e1518. doi: 10.1002/cti2.1518. eCollection 2024.
4
Delivery of a Hepatitis C Virus Vaccine Encoding NS3 Linked to the MHC Class II Chaperone Protein Invariant Chain Using Bacterial Ghosts.使用细菌幽灵递送编码与MHC II类伴侣蛋白恒定链相连的NS3的丙型肝炎病毒疫苗。
Biomedicines. 2024 Feb 26;12(3):525. doi: 10.3390/biomedicines12030525.
5
Prodigiosin-Functionalized Probiotic Ghosts as a Bioinspired Combination Against Colorectal Cancer Cells.原花青素功能化益生菌鬼作为一种针对结直肠癌细胞的生物灵感组合。
Probiotics Antimicrob Proteins. 2023 Oct;15(5):1271-1286. doi: 10.1007/s12602-022-09980-y. Epub 2022 Aug 28.
6
Bacterial Ghosts-Based Vaccine and Drug Delivery Systems.基于细菌幽灵的疫苗和药物递送系统
Pharmaceutics. 2021 Nov 8;13(11):1892. doi: 10.3390/pharmaceutics13111892.
7
Antibacterial effects of antibiotics and cell-free preparations of probiotics against and associated with conjunctivitis.抗生素及益生菌无细胞制剂对结膜炎相关细菌的抗菌作用。
Saudi Pharm J. 2020 Dec;28(12):1558-1565. doi: 10.1016/j.jsps.2020.10.002. Epub 2020 Oct 22.
8
Salmonella-innovative targeting carrier: Loading with doxorubicin for cancer treatment.沙门氏菌创新靶向载体:负载阿霉素用于癌症治疗。
Saudi Pharm J. 2020 Oct;28(10):1253-1262. doi: 10.1016/j.jsps.2020.08.016. Epub 2020 Sep 1.
9
Recent trends and advances in microbe-based drug delivery systems.基于微生物的药物传递系统的最新趋势和进展。
Daru. 2019 Dec;27(2):799-809. doi: 10.1007/s40199-019-00291-2. Epub 2019 Aug 2.
10
Effects of iota-carrageenan on ocular infection in vitro and in vivo.ι-角叉菜胶对体外和体内眼部感染的影响。
J Appl Phycol. 2018;30(4):2601-2610. doi: 10.1007/s10811-018-1435-0. Epub 2018 Mar 13.